000 | 01964cam a2200505Mi 4500 | ||
---|---|---|---|
001 | vtls003274859 | ||
003 | MY-SjTCS | ||
005 | 20200508125119.0 | ||
006 | m o d | ||
007 | cr u| ---a|||| | ||
008 | 171218s2012 ne a ob 001 0 eng d | ||
010 | _z2011-294197 | ||
020 | _z0123919118 | ||
020 | _z9780123919113 | ||
020 | _a9780128042588 | ||
020 | _a0128042583 | ||
020 | _a0123919134 | ||
020 | _a9780123919137 | ||
035 |
_a(OCoLC)988815581 _z(OCoLC)830350770 _z(OCoLC)1011245609 |
||
035 | _a(OCoLC)ocn988815581 | ||
039 | 9 |
_a201712181426 _bshuhada _y201712181209 _zshuhada |
|
040 |
_aZ5A _beng _erda _cZ5A _dMNU _dN _dOCLCF _dYDXCP _dTEFOD _dOCLCO _dCASUM _dOCLCO |
||
049 | _aMAIN | ||
060 | 0 | 0 | _a2012 F-200 |
060 | 1 | 0 |
_aQV 771 _bC64195 2012 |
082 | 0 | 4 |
_a610.724 _223 |
100 | 1 |
_aBrody, Tom, _eauthor. _960555 |
|
245 | 1 | 0 |
_aClinical trials : _bstudy design, endpoints and biomarkers, drug safety, FDA and ICH guidelines / _cTom Brody. |
250 | _aFirst edition. | ||
264 | 1 |
_aAmsterdam : _bElsevier/AP, _c2012. |
|
300 |
_a1 online resource (xxxiii, 638 pages) : _billustrations. |
||
336 |
_atext _2rdacontent |
||
337 |
_acomputer _2rdamedia |
||
338 |
_aonline resource _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
588 | _aMachine converted from AACR2 source record. | ||
588 | _aBased on print version record. | ||
590 |
_aeBooks on EBSCOhost _bAll EBSCO eBooks |
||
650 | 0 |
_aClinical trials. _924193 |
|
650 | 0 |
_aDrug approval. _962141 |
|
655 | 4 | _aElectronic books. | |
776 | 0 | 8 |
_iPrint version: _aBrody, Tom. _tClinical trials _a1st ed. _dAmsterdam : Elsevier/AP, 2012. _w2011294197 _w(OCoLC)772582481 _z9780123919113 |
830 | 0 | _aClinicalKey. | |
856 | 4 | 0 |
_uhttps://ezproxy.taylors.edu.my/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1158706 _zAn electronic book accessible through the World Wide Web; click to view |
999 |
_c130817 _d130817 |